An innovation in artificial intelligence: a model integrating the genome of all existing species
Recently, a group of researchers, under the auspices of the Arc Institute, presented a significant advance in the field of artificial intelligence with the launch of Evo 2, a genomic model that integrates the genomes of living species. Using cutting-edge technologies, this innovation aims to transform medical and biological research by increasing our understanding of diseases. Evo 2 is powered by more than 128,000 complete genomes and relies on a powerful infrastructure provided by Amazon Web Services (AWS). Thanks to a collaboration with Nvidia, approximately 2,000 H100 chips have been deployed to refine this interface, demonstrating the importance of the synergy between AI and biology. The goals of Evo 2: The main objective of Evo 2 is to “accelerate the understanding of complex human diseases.” According to Silvana Konermann, director of Arc, this model should make it possible to identify genetic variants associated with specific pathologies. Next, it will be possible to create new molecules that precisely target these variants, thus facilitating the development of more effective treatments. Discover a revolutionary advance in artificial intelligence with a unique model integrating the genome of all existing species. This innovation promises to transform our understanding of biology and open new perspectives in scientific research. Practical applications and perspectives
With already promising results on a gene linked to breast cancer, researchers were able to analyze genetic mutations with 90% accuracy. This advance in genomic machine learning paves the way for a better understanding of disease mechanisms and the development of more tailored therapeutic solutions. The benefits of this model extend beyond medicine. Evo 2 could improve plant resistance to extreme weather conditions and contribute to the development of enzymes capable of breaking down plastic, highlighting the importance of technological innovation in our modern society.
Evo 2 Project Data
Features
Database
More than 128,000 genomes Partnership Amazon AWS and Nvidia
Main Objective Understanding human diseases Accuracy Rate
Sur le meme sujet
90% for certain analyses
| Reactions from the Scientific Community | This development has been widely praised by the scientific community, which sees Evo 2 as a revolution in AI genomics research. Experts such as those from DeepMind and IBM Watson are expressing growing interest in the synergies between bioinformatics and artificial intelligence. The potential implications of this research extend far beyond simply understanding diseases, touching on broader issues such as sustainability and the preservation of our environment, as highlighted in this report. |
|---|---|
| Examples of future applications: | |
| Development of new drugs targeting specific genetic mutations | Creation of enriched plant varieties adaptable to climate change |
| Inventions of innovative enzymes for processing plastic waste | Discover a revolutionary advance in artificial intelligence with a unique model integrating the genome of all existing species. Explore the implications of this innovation for biology, conservation, and the future of science. |
| https://www.youtube.com/watch?v=WLP4Ov_BFR8 |
Sur le meme sujet
https://www.futura-sciences.com/tech/questions-reponses/intelligence-artificielle-10-applications-intelligence-artificielle-gratuites-indispensables-19952/
Post Comment